Claris Lifescience receives USFDA approval for Flumazenil injection
Claris Lifesciences has received USFDA approval for generic Flumazenil injection used for reversal of the sedative effects of benzodiazepines in the United States. The company […]
USFDA
Strides Shasun receives USFDA approval for Ranitidine
Strides Shasun has received USFDA approval for Ranitidine tablets. The drug Ranitidine is used to treat ulcers of the stomach and intestines and to prevent […]
Cipla receives final ANDA approval for Darifenacin extended-release
Cipla has received final USFDA approval for its Abbreviated New Drug Application (ANDA) for Darifenacin extended-release tablets. Darifenacin extended-release tablets are AB-rated generic equivalents of […]
Jubilant Life Sciences receives USFDA approval for Telmisartan
Jubilant Life Sciences has received USFDA approval for Telmisartan Tablets, used for the treatment of hypertension, in the U.S. market. The final approval is for […]
DRL launches Nitrostat tablets in US
Dr Reddy’s Laboratories has launched Nitroglycerin sublingual tablets, a therapeutic equivalent generic version of Nitrostat (Nitroglycerin) sublingual tablets in the US. The drug which is […]
Cipla receives USFDA approval for generic Bupropion Hydrochloride extended release tablets
Cipla has received final USFDA approval to market generic Bupropion Hydrochloride extended release tablets used for treatment of major depressive disorder through its subsidiary InvaGen […]
Glenmark Pharma receives USFDA approval for Lidocaine Ointment
Glenmark Pharmaceuticals has received final approval from USFDA for its generic version of AstraZeneca’s Xylocaine ointment. The approval is for Lidocaine Ointment USP, 5 per […]
Aurobindo Pharma receives USFDA approval for linezolid injection
Aurobindo Pharma has received final USFDA approval to manufacture and market Linezolid injection which is an anti-infective and is used to treat infections caused by […]
Aurobindo Pharma receives final USFDA approval for Rosuvastatin
Aurobindo Pharma has received final USFDA approval for Rosuvastatin calcium tablets which are prescribed for lowering cholesterol. Rosuvastatin calcium tablets are the generic version of […]
Claris Lifesciences receives USFDA approval for Bupivacaine
Claris Lifesciences has received USFDA approval for generic anaesthetic Bupivacaine injection. The new drug Bupivacaine hydrochloride will be sold in 8.25 per cent dextrose injection […]